Clinical Trial

Prevention of NAFLD and CVD Through Lifestyle Intervention

Study acronym: MAUCO+
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 19, 2024 (before its estimated April 28, 2025 completion). Its status may not reflect the trial's current state.
Summary
Prevention of non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease (CVD) through lifestyle intervention (MAUCO+) is a clinical trial that aims to improve sarcopenia, aerobic capacity, body composition, and lipid profile, insulin resistance, cardiovascular risk, NAFLD, and maintain a healthier lifestyle. Through the implementation of physical activity and nutritional programs.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2022-11-09; most recent amendment 2024-11-17.
Trial Details
NCT Number NCT05618626
Lead Sponsor Pontificia Universidad Catolica de Chile
Conditions Non-Alcoholic Fatty Liver Disease, Gallstone Disease
Enrollment 300 participants
Start Date 2021-09-27
Primary Completion 2025-04-28 (estimated)
Study Completion 2025-04-30 (estimated)
Updated on ClinicalTrials.gov 2024-11-19